The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Personalis, Inc(NASDAQ:PSNL) 
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and dia...
Website: http://www.personalis.com
Founded: 2011
IPO Price: $17 (Jun 20, 2019)
Full Time Employees: 181
CEO: John S. West
Sector: Healthcare
Industry: Diagnostics & Research
Personalis Days Payable Outstanding ttm (DPO)
Personalis Days Receivable Outstanding ttm (DSO)
Personalis Days Inventory Outstanding ttm (DIO)
Personalis Op Cashflow Per Share ttm
Personalis Free Cashflow Per Share ttm
Personalis Cash Per Share ttm
Personalis P/S ratio ttm
Personalis (GAAP) P/E ratio ttm
Personalis P/B ratio ttm
No extra charts and metrics for this ticker.